No significant differences were observed between the CM and TBM groups regarding sex distribution or prior diagnosis of diabetes or tumor; red blood cell or platelet count; hemoglobin, C-reactive protein, procalcitonin, or albumin level; or neutrophil, monocyte, or lymphocyte percentage. This evidence concerns the gene CRP and neoplasm.